The JAK inhibitor Tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through Mir-149-5p
Yen‐Shuo Chiu, Oluwaseun Adebayo Bamodu, Iat-Hang Fong, Wei‐Hwa Lee, Chih-Cheng Lin, Chen-Hsu Lu, Chi‐Tai Yeh
Topics & Concepts
TofacitinibMedicineProinflammatory cytokineCancer researchOsteoarthritisInflammationArthritisTumor necrosis factor alphaInternal medicinePharmacologyRheumatoid arthritisPathologyAlternative medicineOsteoarthritis Treatment and MechanismsRheumatoid Arthritis Research and TherapiesMicroRNA in disease regulation